Chaperone Therapeutics, Inc.
Biotechnology company · Chapel Hill, North Carolina, United States
Chaperone Therapeutics, Inc. is a biotechnology company headquartered in Chapel Hill, North Carolina, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.2 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $456,569 sold in a notice filed in 2017.
Chaperone Therapeutics at a glance
What does Chaperone Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.2 million in total (2016 to 2017). NIH funding came from the National Institute on Aging, National Institute on Deafness and Other Communication Disorders.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $456,569 sold (2017).
Frequently asked questions about Chaperone Therapeutics
Where is Chaperone Therapeutics headquartered?
Chaperone Therapeutics, Inc. is headquartered in Chapel Hill, North Carolina, United States.
What does Chaperone Therapeutics do?
Chaperone Therapeutics, Inc. is a biotechnology company.
Similar companies
- BioKier, Inc.Chapel Hill, North Carolina, United States
- Redbud Labs, Inc.Chapel Hill, North Carolina, United States
- Clinical Tools, IncChapel Hill, North Carolina, United States
- OncoTrap, Inc.Chapel Hill, North Carolina, United States
- Areteia Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Vascular Pharmaceuticals, Inc.Chapel Hill, North Carolina, United States
- Falcon Therapeutics, Inc.Chapel Hill, North Carolina, United States
- Theravida, Inc.Chapel Hill, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences